Current Assets

Edwards Lifesciences·Balance Sheet Statement·15 metrics

Breakdown

Loading...

Metrics

Accounts receivable, net

Available-for-Sale Debt Securities - Amortized Cost (Due Within One Year)

AFS and Trading Securities - Unrealized Loss Position (>=12 Months)

AFS and Trading Securities - Unrealized Loss Position (<12 Months) Fair Value

Cash and cash equivalents

Finished goods

Other current assets

Other accounts receivable (net of allowances of $37 in 2026 and $37 in 2025)

Derivative assets

Raw materials

Work in process

Inventories

Prepaid expenses and other current assets

Restricted cash

Total current assets